USFloors has received a Notice of Allowance for its COREtec patent application. The Notice of Allowance, which is posted on the U.S. Patent and Trademark Office (USPTO) website, reads, "The application identified above has been examined ...
Tags: flooring product, Construction
IntelGenx, a Canadian drug delivery company focusing on oral drug delivery, has announced that it has received a notice of allowance from the US Patent and Trademark Office for its Patent Application Serial No. 11/647,033 entitled ...
Tags: IntelGenx, Proprietary Technology
BrainStorm Cell Therapeutics has received a notice of allowance from the US Patent Office for its ‘Mesenchymal Stem Cells for the Treatment of CNS Diseases’ (serial number 12/994,761) patent application. This patent relates to ...
Tags: Cell Technology Patent, Medicine
Adamis Pharmaceuticals has announced an important addition to its intellectual property with receipt of a notice of allowance of patent claims supporting its cancer immunotherapy portfolio in the US. Notice of allowance is the final step ...
Tags: Cancer Immunology, Cancer, Cancer cure
Canadian FreeFit distributor Jeff Knowles utilizes double-sided Gecko Tape and FreeFit for a fast install around normally tricky LVT obstacles like heating vents and large windows. FreeFit, the original line of loose lay luxury vinyl ...
Tags: FreeFit, notice of allowance, U.S.patent, Samuel Apicelli
US-based clinical development firm AltheRx Pharmaceuticals has received a notice of allowance for its patent application from the US Patent and Trademark Office (USPTO) for the use of solabegron in combination with antimuscarinics at both ...
US-based biotechnology firm GeoVax Labs has received a notice of allowance from the US Patent and Trademark Office (USPTO) for patent that covers compositions, methods and uses of the company's DNA/MVA vaccine in eliciting cellular and ...
Tags: Geovax Labs, HIV/Aids Vaccine
US-based MMRGlobal (MMR) will receive two additional US patents covering methods of making compositions for its B-cell vaccine technologies. The patent entitled 'Method and Composition for Altering a B-cell Mediated Pathology', will be ...
The US Patent & Trademark Office (USPTO) has issued a notice of allowance for Elorac's patent application regarding novel acne therapy. The US patent is entitled "Method and Composition for Treating Nodulocystic and Conglobate Acne ...
Tags: Acne Therapy, Medicine
Life sciences company Quick-Med Technologies has received notice of allowance for additional new US patent protecting new, non-leaching Nimbus antimicrobial technology. A total of 41 claims were allowed by the US Patent and Trademark ...
Quick-Med Technologies, a US-based life sciences company, obtained a notice-of-allowance for a new US patent covering Nimbus, its antimicrobial technology custom designed for wound care and other medical applications. The U.S. Patent and ...
The US Patent and Trademark Office (USPTO) has issued a notice of allowance for Sangamo BioSciences’ patent application entitled ‘Novel DNA-binding Proteins and Uses Thereof.’ Claims cover the critical components of TALE ...
The USPTO has issued a notice of allowance for GW Pharmaceuticals' patent application regarding Sativex formulation spray device. The patent alleges a metered valve pump spray device comprising a liquid cannabis extract, in propylene ...
Tags: USPTO, GW Pharmaceuticals
Neuralstem has obtained notice of allowance for a patent that covers various methods to use expanded spinal cord stem cells such as NSI-566 to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The company completed Phase ...
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to Arrowhead Research's patent application NO.13/336,028 covering dynamic polyconjugate (DPC) siRNA delivery system. The patent entitled, 'In Vivo ...
Tags: Arrowhead, NOA, therapeutic area targets